EUVIMEDEUVIMED entdecken
Open Access

Structural insight into CD93 recognition by IGFBP7

Yueming Xu, Yi Sun, Yuwen Zhu, Gaojie Song

Structure · 2024

DOI: 10.1016/j.str.2023.12.011 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Structure, 2024. Verfasst von Yueming Xu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Frontiers Science Center of Genome Editing and Cell Therapy, Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences…. Hauptthemen laut MEDLINE: Endothelial Cells, Neoplasms. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Institutes of Health, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The CD93/IGFBP7 axis proteins are key factors expressed in endothelial cells (EC) that mediate EC angiogenesis and migration. Their upregulation contributes to tumor vascular abnormality and a blockade of this interaction promotes a favorable tumor microenvironment for therapeutic interventions. However, the interactions of these proteins with each other remain unclear. In this study, we determined a partial structure of the human CD93-IGFBP7 complex comprising the EGF1 domain of CD93 and the IB domain of IGFBP7. Mutagenesis studies confirmed interactions and specificities. Cellular and mouse tumor studies demonstrated the physiological relevance of the CD93-IGFBP7 interaction in EC angiogenesis. Our study provides leads for the development of therapeutic agents to precisely disrupt unwanted CD93-IGFBP7 signaling in the tumor microenvironment. Additionally, analysis of the CD93 full-length architecture provides insights into how CD93 protrudes on the cell surface and forms a flexible platform for binding to IGFBP7 and other ligands.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Endothelial CellsNeoplasmsAnimalsHumansMiceMembrane GlycoproteinsReceptors, ComplementSignal TransductionTumor MicroenvironmentInsulin-Like Growth Factor Binding Proteins

Stichwörter der Autor:innen

CD93EC angiogenesisIGFBP7crystal structuretumor therapy

Substanzen

Membrane GlycoproteinsReceptors, Complementinsulin-like growth factor binding protein-related protein 1Insulin-Like Growth Factor Binding Proteinscomplement 1q receptor

Autor:innen und Institutionen

  • Shanghai Frontiers Science Center of Genome Editing and Cell Therapy, Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai 2…
  • Department of Surgery, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
  • Department of Surgery, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA. Electronic address: yuwen.zhu@cuanschutz.edu.

Förderung

  • NCI NIH HHS
  • National Institutes of Health
  • National Natural Science Foundation of China
  • Science and Technology Commission of Shanghai Municipality

Zitieren

APA

Xu, Y., Sun, Y., Zhu, Y., & Song, G. (2024). Structural insight into CD93 recognition by IGFBP7. Structure. https://doi.org/10.1016/j.str.2023.12.011

Vancouver

Xu Y, Sun Y, Zhu Y, Song G. Structural insight into CD93 recognition by IGFBP7. Structure. 2024. doi:10.1016/j.str.2023.12.011

BibTeX
@article{Xu2024,
  author = {Xu, Yueming and Sun, Yi and Zhu, Yuwen and Song, Gaojie},
  title = {Structural insight into CD93 recognition by IGFBP7},
  journal = {Structure},
  year = {2024},
  doi = {10.1016/j.str.2023.12.011}
}
Kostenlos starten →